×







We sell 100% Genuine & New Books only!

Management Of Neuroendocrine Tumors Of The Pancreas And Digestive Tract at Meripustak

Management Of Neuroendocrine Tumors Of The Pancreas And Digestive Tract by RAYMOND, SPRINGER

Books from same Author: RAYMOND

Books from same Publisher: SPRINGER

Related Category: Author List / Publisher List


  • Price: ₹ 8958.00/- [ 23.00% off ]

    Seller Price: ₹ 6897.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)RAYMOND
    PublisherSPRINGER
    ISBN9782817804293
    Pages236
    BindingHardbound
    LanguageEnglish
    Publish YearMarch 2014

    Description

    SPRINGER Management Of Neuroendocrine Tumors Of The Pancreas And Digestive Tract by RAYMOND

    This book pursues a multidisciplinary approach, presenting chapters with updated information on various aspects of treatment for patients with neuroendocrine tumors. Authors have been selected from expert centers in Europe and the United States. The goal of this book is to comprehensively summarize recent data and provide inspiring ideas to optimize the care of patients with neuroendocrine tumors. Neuroendocrine tumors are fascinating multifaceted diseases that can primarily localize in many organs with various presentations. These tumors are rare but their increasing incidence renders likely that physicians caring for cancers may have either already faced or may be certainly exposed to diagnose and/or treat a patient with neuroendocrine tumors. Over the last years, novel therapeutic options have emerged for neuroendocrine tumors, profoundly challenging practices that had previously been the standards for decades. These include - but are not limited to - somatostatin analogues, targeted therapies such as tyrosine kinase and mTOR inhibitors, antiangiogenic compounds, but also peptide-receptor targeted therapy or rad...



    Book Successfully Added To Your Cart